📰 Development Or Manufacturing News
Development Or Manufacturing News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Development Or Manufacturing. Real-time updates on events, politics, business and more.
May 19, 2022
/PRNewswire/ -- Vedere Bio II, Inc., a company developing transformative, next-generation therapies for vision restoration and preservation, today will present...
May 11, 2022
/PRNewswire/ -- LogicBio® Therapeutics, Inc. (Nasdaq: LOGC), a clinical-stage genetic medicine company, today announced that it will present four abstracts...
May 9, 2022
/PRNewswire/ -- OBiO Technology (Shanghai) Corp., Ltd. (OBiO, SSE:688238.SH), a gene and cell therapy-focused biotechnology company, serving as a contract...
May 5, 2022
SQZ’s Point-of-Care (POC) Manufacturing Platform Shows Promising Results with Ability to Produce Cell Therapies at Scale in Under 10 HoursCo-Development of Research-Use-Only System with STEMCELL Technologies to Help Drive Cell Therapy Innovation by the Broader Scientific CommunityPresentations on the POC Manufacturi...
May 3, 2022
/PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced presentations at the American Society of Gene & Cell Therapy (ASGCT) 25th Annual Meeting, taking...
May 2, 2022
/PRNewswire/ -- Alcyone Therapeutics Inc. ("Alcyone"), a biotechnology company pioneering next-generation precision gene-based therapies for complex...
May 2, 2022
/PRNewswire/ -- Vedere Bio II, Inc., a company developing transformative, next-generation therapies for vision restoration and preservation, today announced...
May 2, 2022
/PRNewswire/ -- Alcyone Therapeutics Inc. ("Alcyone"), a biotechnology company pioneering next-generation precision gene-based therapies for complex...
May 2, 2022
CAMBRIDGE, Mass., May 2, 2022 /PRNewswire/ -- Vedere Bio II, Inc., a company developing transformative, next-generation therapies for vision resto...